Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Turk J Med Sci ; 51(2): 464-472, 2021 04 30.
Article in English | MEDLINE | ID: mdl-33021755

ABSTRACT

Background/aim: Oral antibiotics are usually used to treat asymptomatic bacteriuria during the perioperative period of joint replacement. However, there is no unified conclusion as to whether asymptomatic bacteriuria causes infection around joint prostheses, and the efficacy of antibiotics is unknown. Materials and methods: We systematically searched PubMed, CNKI, Ovid, Cochrane Library, EMBASE, manual research, and references of relevant articles up to January 1, 2020, to identify and compare observational studies. The Cochrane systematic review method was used, and Review Manager 5.3 software was used for analysis. Results: Nine articles were included in the analysis, involving 29,844 cases of joint arthroplasty and 2366 cases of asymptomatic bacteriuria. Periprosthetic joint infection had a significantly higher incidence in the asymptomatic bacteriuria group than in the nonasymptomatic bacteriuria group (Odds Ratio: OR = 3.15, 95% CI: 1.23­8.02, P = 0.02). Seven of the nine articles reported the use of antibiotics for treating perioperative asymptomatic bacteriuria and there was no significant difference in the incidence of periprosthetic joint infection between the two groups (OR = 1.64, 95% CI: 0.84­3.23, P = 0.15). Conclusion: The occurrence of asymptomatic bacteriuria in the perioperative period of joint arthroplasty is a risk factor for periprosthetic joint infection, and the use of antibiotics for asymptomatic bacteriuria does not change the rate of incidence.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Arthroplasty, Replacement, Hip/adverse effects , Bacteriuria/drug therapy , Perioperative Care/methods , Perioperative Period , Prosthesis-Related Infections/drug therapy , Aged , Bacteria/growth & development , Bacteriuria/complications , Bacteriuria/microbiology , Female , Humans , Male , Prosthesis-Related Infections/epidemiology , Prosthesis-Related Infections/etiology , Prosthesis-Related Infections/microbiology
2.
National Journal of Andrology ; (12): 466-470, 2008.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-319211

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effects of the Chinese herbal medicine of Longbixiao (LBX) Capsule on the expressions of TGF-beta1 and Smoothelin in human prostatic stromal cells cultured in vitro.</p><p><b>METHODS</b>Blood serum medicated with LBX was incubated with the stromal cells isolated from men with benign prostatic hyperplasia (BPH) and cultured in vitro. The mRNA expression levels of TGF-beta1 and Smoothelin were detected by real-time RT-PCR and other relevant techniques.</p><p><b>RESULTS</b>In the high and low concentration groups, the gene relative expressions of TGF-beta1 were (0.158 +/- 0.020) and (0.169 +/- 0.020) , while those of Smoothelin were (0.035 +/- 0.007) and (0.036 +/- 0.007) respectively, both significantly decreased in comparison with the control group(P < 0.01).</p><p><b>CONCLUSION</b>LBX reduces the mRNA expressions of TGF-beta1 and Smoothelin in human prostatic stromal cells and can be used in the treatment of BPH.</p>


Subject(s)
Animals , Humans , Male , Rabbits , Capsules , Cells, Cultured , Cytoskeletal Proteins , Genetics , Dose-Response Relationship, Drug , Drugs, Chinese Herbal , Chemistry , Pharmacology , Gene Expression , Muscle Proteins , Genetics , Prostatic Hyperplasia , Pathology , Reverse Transcriptase Polymerase Chain Reaction , Serum , Chemistry , Stromal Cells , Metabolism , Pathology , Transforming Growth Factor beta1 , Genetics
3.
Chinese Journal of Oncology ; (12): 479-481, 2004.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-254289

ABSTRACT

<p><b>OBJECTIVE</b>To find sensitive and specific micro-metastic markers for prostate cancer.</p><p><b>METHODS</b>Using nested reverse transcription-PCR, we examined the expression of PSA, hK2 and PSMA mRNA in peripheral blood mononuclear cells of 51 patients with prostate cancer, 33 patients with benign prostate hyperplasia (BPH) and 32 normal young people.</p><p><b>RESULTS</b>The expression rates of PSA, hK2 and PSMA mRNA were 52.9%, 43.1% and 64.7%, respectively in prostate cancer group, and 6.2%, 7.7% and 4.6%, respectively in control group (BPH patients and normal young people) with statistical significance (P < 0.01). Although the expression rate of PSA and hK2 mRNA increased with cancer progression, there was no statistical significance among patients in different stages. The expression rate of PSMA mRNA was higher than that of PSA and hK2 mRNA in each clinical stage.</p><p><b>CONCLUSION</b>PSMA mRNA expression detected by nested RT-PCR is of greater value for the diagnosis, therapy choice and prognostic evaluation of prostate cancer patients.</p>


Subject(s)
Aged , Humans , Male , Middle Aged , Antigens, Surface , Blood , Biomarkers, Tumor , Blood , Glutamate Carboxypeptidase II , Blood , Neoplasm Invasiveness , Neoplasm Staging , Prostate-Specific Antigen , Blood , Prostatic Hyperplasia , Blood , Pathology , Prostatic Neoplasms , Blood , Pathology , Tissue Kallikreins , Blood
SELECTION OF CITATIONS
SEARCH DETAIL
...